Azvudine efficacy in reducing mortality in COVID-19 patients

Background Several therapeutic drugs have been authorized for the treatment of patients with Coronavirus disease 2019 (COVID-19). However, further research on the mechanisms of action, efficacy, and target populations of these novel therapeutic drugs are necessary. This study included mild, moderate...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	European journal of medical research Ročník 29; číslo 1; s. 625 - 10
Hlavní autoři:	Zhong, Zhen, Liu, Xiao-feng, Zhou, Xiao-zhong, Zhong, Jia-ning, Zhou, Li-cheng, Li, Rong, Liu, Xian-fa
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London BioMed Central 26.12.2024 BioMed Central Ltd BMC
Témata:	Adult Aged Analysis Antiviral agents Antiviral Agents - therapeutic use Azvudine Biomedicine Coronaviruses COVID-19 COVID-19 - mortality COVID-19 Drug Treatment Female Hospital patients Humans Infectious Diseases Internal Medicine Male Medical research Medicine Medicine & Public Health Medicine, Experimental Middle Aged Mortality Oncology Patient outcomes Real-world study Retrospective Studies SARS-CoV-2 - drug effects Surgery Treatment Outcome COVID-19 Azvudine Real-world study
ISSN:	2047-783X, 0949-2321, 2047-783X
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!